Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Author
Hammerschlag, M RJournal title
Antimicrobial agents and chemotherapyDate Published
1994-09Publication Volume
38Publication Issue
9Publication Begin page
1873Publication End page
8
Metadata
Show full item recordCitation
Hammerschlag MR. Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae. Antimicrob Agents Chemother. 1994 Sep;38(9):1873-8. doi: 10.1128/AAC.38.9.1873. PMID: 7810992; PMCID: PMC284655.Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
Related articles
- In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae.
- Authors: Pereyre S, de Barbeyrac B, Renaudin H, Poutiers F, Bébéar C, Bébéar CM
- Issue date: 2001 Feb
- In Vitro Activity of Levonadifloxacin (WCK 771) against Chlamydia pneumoniae.
- Authors: Kohlhoff S, Huerta N, Hammerschlag MR
- Issue date: 2019 Aug
- Potential for antimicrobial resistance in Chlamydia pneumoniae.
- Authors: Stamm WE
- Issue date: 2000 Jun
- [Diagnosis and therapy of Chlamydia pneumoniae and trachomatis].
- Authors: Freidank H
- Issue date: 1997 Oct
- Efficacy of benzoxazinorifamycins in a mouse model of Chlamydia pneumoniae lung infection.
- Authors: Campbell LA, Kuo CC, Suchland RJ, Rothstein DM
- Issue date: 2008 May